NEOGLIM-M2 Tablets
Composition
Each Uncoated Bi-layered Tablet Contains: - Glimepiride 2mg + Metformin 500mg in Prolonged Release form
Indication
Glimepiride + Metformin is a clinically proven combination of two antidiabetic medicines used to manage type 2 diabetes mellitus in adults. It plays a crucial role in controlling blood sugar levels and reducing the risk of long-term diabetes-related complications.
This formulation combines the power of Glimepiride 2 mg + Metformin 500 mg, found in products like Neoglim M2, to help maintain optimal glucose levels. Glimepiride, a sulfonylurea, works by stimulating the pancreas to release more insulin—your body’s natural blood sugar regulator. Metformin, from the biguanide class, complements this action by reducing glucose production in the liver, slowing its absorption in the gut, and improving insulin sensitivity.
By working together, these two medicines provide a synergistic effect that results in better glycemic control compared to either medicine alone. This is key to minimizing the risk of severe complications such as kidney damage, eye disorders, nerve problems, and even amputation in poorly managed diabetes.
Neoglim M2 tablets, available as Neoglim M2 tab, Neoglim M2 tablet, and Neoglim M2 tablets, are part of the class of glimepiride and metformin hydrochloride prolonged release tablets IP. These are especially beneficial for patients who need sustained glucose control throughout the day.
When combined with healthy lifestyle habits, Neoglim M2 empowers you to take charge of your diabetes—one dose, one step, one day at a time.
Contraindication
Nausea, Diarrhoea, Headache, Upper respiratory tract infection, Dizziness, Flatulence
Storage
Cool & Dry Place
Dosage
As directed by a Medical Practitioner or Physician.
Inquire Now